Glaukos — a global leader in pioneering surgical treatments for chronic eye diseases — has chosen RadiusXR as their exclusive partner to bring a vision care diagnostics offering to market. Our strategic partnership provides Radius access to capital, further investments in product development, and a dedicated Glaukos sales force to commercialize Radius, thus accelerating growth.
RadiusXR has been endorsed by leading ophthalmologists, who have joined our clinical advisory board as scientific advisors to work closely with us in developing new technologies. Our powerful support from the investor community includes well-known figures with decades of experience in healthcare. Our company leadership and team includes a winning mix of software technologists and ophthalmology veterans.
Radius has brought together a diverse range of talents and expertise to create the future of global vision care.
On a path to being the vision care category leader, Radius has achieved significant milestones. These include meeting regulator standards, completing clinical validation studies, industry awards, and receiving a peer-reviewed publication in ARVO, a prestigious scientific journal. Radius has successfully established crucial strategic partnerships to facilitate robust growth in optometry, ophthalmology and at-home vision care.